Clinical Trial: Safety & Efficacy of RenalGuard(R) Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123935) titled 'Safety & Efficacy of RenalGuard(R) Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury' on July 29.

Brief Summary: The goal of this clinical trial is to assess the effect of RenalGuard Therapy in reducing the rates of Acute Kidney Injury (AKI) within 72 hours after cardiac surgery in patients at risk of developing Cardiac Surgery Associated AKI (CSA-AKI) compared to standard-of-care (SoC).

The study is planned to be conducted in 2 clinical sites in the Malaysia - Universiti Malaya Medical Centre and Institut Jantung Negara, Kuala Lumpur, Malaysia.

Participants will be randomized (1:1) to one of the two stud...